全文获取类型
收费全文 | 5507篇 |
免费 | 511篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 285篇 |
妇产科学 | 79篇 |
基础医学 | 650篇 |
口腔科学 | 102篇 |
临床医学 | 693篇 |
内科学 | 1219篇 |
皮肤病学 | 259篇 |
神经病学 | 308篇 |
特种医学 | 508篇 |
外科学 | 565篇 |
综合类 | 140篇 |
一般理论 | 2篇 |
预防医学 | 521篇 |
眼科学 | 51篇 |
药学 | 452篇 |
2篇 | |
中国医学 | 3篇 |
肿瘤学 | 248篇 |
出版年
2021年 | 63篇 |
2020年 | 46篇 |
2019年 | 58篇 |
2018年 | 82篇 |
2017年 | 55篇 |
2016年 | 80篇 |
2015年 | 91篇 |
2014年 | 114篇 |
2013年 | 161篇 |
2012年 | 196篇 |
2011年 | 215篇 |
2010年 | 184篇 |
2009年 | 155篇 |
2008年 | 229篇 |
2007年 | 247篇 |
2006年 | 221篇 |
2005年 | 222篇 |
2004年 | 180篇 |
2003年 | 161篇 |
2002年 | 150篇 |
2001年 | 163篇 |
2000年 | 162篇 |
1999年 | 135篇 |
1998年 | 170篇 |
1997年 | 187篇 |
1996年 | 161篇 |
1995年 | 147篇 |
1994年 | 141篇 |
1993年 | 127篇 |
1992年 | 113篇 |
1991年 | 110篇 |
1990年 | 114篇 |
1989年 | 103篇 |
1988年 | 108篇 |
1987年 | 99篇 |
1986年 | 114篇 |
1985年 | 125篇 |
1984年 | 77篇 |
1983年 | 81篇 |
1982年 | 58篇 |
1981年 | 52篇 |
1980年 | 51篇 |
1979年 | 44篇 |
1978年 | 47篇 |
1977年 | 50篇 |
1976年 | 62篇 |
1975年 | 57篇 |
1974年 | 49篇 |
1973年 | 34篇 |
1972年 | 32篇 |
排序方式: 共有6099条查询结果,搜索用时 15 毫秒
1.
2.
3.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
4.
5.
Nine hundred and three patients undergoing diagnostic peritoneal lavage (DPL) over a 6-year period were retrospectively reviewed to evaluate the utility of the white blood cell (WBC) count in the lavage fluid. Eleven patients (1.2%) had dialysate WBC counts greater than 500/mm3, with erythrocyte counts less than 10(5)/mm3. Nine of these patients who were lavaged within 4 hours of injury had no intra-abdominal pathology. Two patients, lavaged after 4 hours, demonstrated intra-abdominal injury. Two hundred twenty-three patients (24.7%) had grossly clear dialysate which was not sent for laboratory analysis. None of these patients required laparotomy. We conclude that the WBC count in DPL fluid is of no diagnostic value in victims of blunt abdominal trauma who are lavaged within 4 hours of injury. In addition, laboratory analysis of clear dialysate is not required in these patients. 相似文献
6.
7.
A metropolitan experience with infrainguinal revascularization. Operative risk and late results in northeastern Ohio 总被引:1,自引:0,他引:1
T D Rafferty J C Avellone C J Farrell N R Hertzer F R Plecha R S Rhodes W V Sharp J M Rogers 《Journal of vascular surgery》1987,6(4):365-371
Despite being of fundamental importance, the late results of major arterial reconstruction rarely have been documented throughout a large metropolitan area. In this study of 932 patients entered into the computer registry of the Cleveland Vascular Society, 19 surgeons representing 13 community hospitals and referral centers in Cleveland and Akron report the intermediate-term outcome during a mean interval of 35 months after infrainguinal lower extremity revascularization performed in northeastern Ohio from 1978 through 1982. Operative risk (5%), the early amputation rate (7%), and actuarial 5-year survival (48% to 55%) for patients with rest pain or tissue necrosis were significantly worse (p less than 0.05) than comparable figures (0.6%, 0%, and 77%, respectively) for others who underwent procedures for disabling claudication. Although both materials had similar success above the knee, the cumulative 3-year patency rate of autogenous vein bypass to the distal popliteal (69% to 88%; p less than 0.05) and tibioperoneal arteries (43%; 0.05 less than p less than 0.1) was superior to the results of polytetrafluoroethylene grafts (32% to 50% and 19%, respectively). Moreover, polytetrafluoroethylene grafts required reoperations at three times the rate of vein grafts to maintain limb salvage. 相似文献
8.
Molecular determinants of cetuximab efficacy. 总被引:17,自引:0,他引:17
Daniel Vallb?hmer Wu Zhang Michael Gordon Dong Yun Yang Jim Yun Oliver A Press Katrin E Rhodes Andy E Sherrod Syma Iqbal Kathleen D Danenberg Susan Groshen Heinz-Josef Lenz 《Journal of clinical oncology》2005,23(15):3536-3544
PURPOSE: To investigate whether mRNA expression levels of cyclin D1 (CCND1), cyclooxygenase 2 (Cox-2), epidermal growth factor receptor (EGFR), interleukin 8 (IL-8), and vascular endothelial growth factor (VEGF), all members of the EGFR signaling pathway, are associated with clinical outcome in patients with EGFR-expressing metastatic colorectal cancer (CRC) treated with cetuximab. PATIENTS AND METHODS: Thirty-nine patients with metastatic CRC, refractory to both irinotecan and oxaliplatin, were enrolled on IMCL-0144 and treated with single-agent cetuximab. The intratumoral mRNA levels of CCND1, Cox-2, EGFR, IL-8, and VEGF were assessed from paraffin-embedded tissue samples using laser-capture microdissection and quantitative real-time polymerase chain reaction. RESULTS: There were 21 women and 18 men with a median age of 64 years (range, 35 to 83 years). Higher gene expression levels of VEGF were associated with resistance to cetuximab (P = .038; Kruskal-Wallis test). The combination of low gene expression levels of Cox-2, EGFR, and IL-8 was significantly associated with overall survival (13.5 v 2.3 months; P = .028; log-rank test). Both findings were independent of skin toxicity that was itself significantly correlated to survival. Patients with a lower mRNA amount of EGFR had a longer overall survival compared with patients that had a higher mRNA amount (7.3 v 2.2 months; P = .09; log-rank test). Patients with lower expression of Cox-2 had a significantly higher rate of grade 2 to 3 skin reactions under cetuximab treatment. CONCLUSION: This pilot study suggests that gene expression levels of Cox-2, EGFR, IL-8, and VEGF in patients with metastatic CRC may be useful markers of clinical outcome in single-agent cetuximab treatment. 相似文献
9.
10.